SSX8 antibody (AA 21-120) (FITC)
Quick Overview for SSX8 antibody (AA 21-120) (FITC) (ABIN760608)
Target
Reactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 21-120
-
Cross-Reactivity
- Mouse
-
Predicted Reactivity
- Human
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human SSX8
-
Isotype
- IgG
-
-
anti-Synovial Sarcoma, X Breakpoint 8 (SSX8) (C-Term) antibody
SSX8 Reactivity: Human WB Host: Rabbit Polyclonal unconjugated
-
-
Application Notes
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Expiry Date
- 12 months
-
-
- SSX8 (Synovial Sarcoma, X Breakpoint 8 (SSX8))
-
Alternative Name
- SSX8
-
Background
-
Synonyms: Protein SSX8, SSX 8, SSX-8, Synovial sarcoma X breakpoint 8, SSX8_HUMAN.
Background: SSX8 belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X,18) translocation characteristically found in all synovial sarcomas.
Target
-
